U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 150 points on Monday.
Shares of Tesla, Inc TSLA fell in today's pre-market trading.
Tesla CEO Elon Musk and Vice President of Finance Sendil Palani addressed allegations of the EV company evading taxes in posts on X over the weekend. The company did not evade tax but carried it forward as per an Internal Revenue Service (IRS) provision, they said.
Tesla shares fell 1.2% to $357.16 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Pliant Therapeutics, Inc. PLRX dipped 54.5% to $3.54 in pre-market trading after the company issued an update on BEACON-IPF, a Phase 2b/3 trial in patients with idiopathic pulmonary fibrosis.
- Semtech Corporation SMTC shares tumbled 25.2% to $40.75 in pre-market trading. Semtech shares fell around 10% on Friday after Baird cut its price target on the stock from $80 to $60.
- Oriental Rise Holdings Limited ORIS declined 20.2% to $0.91 in pre-market trading after falling more than 5% on Friday.
- Replimune Group, Inc. REPL fell 19.6% to $11.21 in pre-market trading. Replimune announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
- Maze Therapeutics, Inc. MAZE fell 9.5% to $12.11 in pre-market trading. Maze Therapeutics shares gained around 3% on Friday after the company announced that the first patient has been dosed in the company’s Phase 2 clinical trial, the HORIZON Study, of MZE829 in patients with APOL1 kidney disease.
- Dogness (International) Corporation DOGZ fell 6.6% to $33.00 in pre-market trading.
- The Manitowoc Company, Inc. MTW shares dipped 6.4% to $9.12 in pre-market trading.
- Option Care Health, Inc. OPCH fell 6% to $29.13 in pre-market trading.
- Celestica Inc. CLS fell 3.2% to $125.52 in pre-market trading.
- ON Semiconductor Corporation ON shares declined 2.1% to $50.20 in pre-market trading ahead of quarterly earnings.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.